Cargando…

Molecular Pathology, Diagnostics and Therapeutics: A Story of Success in 2022

Detalles Bibliográficos
Autor principal: Bustin, Stephen A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002953/
https://www.ncbi.nlm.nih.gov/pubmed/36902493
http://dx.doi.org/10.3390/ijms24055063
_version_ 1784904493814513664
author Bustin, Stephen A.
author_facet Bustin, Stephen A.
author_sort Bustin, Stephen A.
collection PubMed
description
format Online
Article
Text
id pubmed-10002953
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100029532023-03-11 Molecular Pathology, Diagnostics and Therapeutics: A Story of Success in 2022 Bustin, Stephen A. Int J Mol Sci Editorial MDPI 2023-03-06 /pmc/articles/PMC10002953/ /pubmed/36902493 http://dx.doi.org/10.3390/ijms24055063 Text en © 2023 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Editorial
Bustin, Stephen A.
Molecular Pathology, Diagnostics and Therapeutics: A Story of Success in 2022
title Molecular Pathology, Diagnostics and Therapeutics: A Story of Success in 2022
title_full Molecular Pathology, Diagnostics and Therapeutics: A Story of Success in 2022
title_fullStr Molecular Pathology, Diagnostics and Therapeutics: A Story of Success in 2022
title_full_unstemmed Molecular Pathology, Diagnostics and Therapeutics: A Story of Success in 2022
title_short Molecular Pathology, Diagnostics and Therapeutics: A Story of Success in 2022
title_sort molecular pathology, diagnostics and therapeutics: a story of success in 2022
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002953/
https://www.ncbi.nlm.nih.gov/pubmed/36902493
http://dx.doi.org/10.3390/ijms24055063
work_keys_str_mv AT bustinstephena molecularpathologydiagnosticsandtherapeuticsastoryofsuccessin2022